News
TTNP
7.38
+2.04%
0.15
12 Health Care Stocks Moving In Wednesday's After-Market Session
Avalo Therapeutics (NASDAQ:AVTX) shares moved upwards by 215.8% to $15.0 during Wednesday's after-market session. The company's Q4 earnings report came out today. Fresh2 Group stock rose upwards by 5.26% as well.
Benzinga · 21h ago
12 Health Care Stocks Moving In Tuesday's After-Market Session
Apollomics (NASDAQ:APLM) stock rose 10.9% to $0.61 during Tuesday's after-market session. The company's, Q4 earnings came out today. Cara Therapeutics shares moved upwards by 7.36% and Iridex stock increased by 5.52%. Losers Akili and Mira Pharmaceuticals were the biggest losers in the market.
Benzinga · 1d ago
Weekly Report: what happened at TTNP last week (0318-0322)?
Weekly Report · 3d ago
12 Health Care Stocks Moving In Monday's Intraday Session
Fresh2 Group (NASDAQ:FRES) shares rose 41.7% to $0.66 during Monday's regular session. Akso Health Group stock moved upwards by 29.0%. ChromaDex stock rose upwards by 27.91%. Trxade Health shares declined by 33.0% during the session.
Benzinga · 03/18 17:31
WIMI, TTNP and STI among mid-day movers
On the Move WIMI, TTNP and STI among mid-day movers. Trinity Place Holdings (TPHS) and Solidion Technology (STI) gain. Global Mofy Metaverse Ltd (GMM) and Wimi Hologram Cloud are among the losers.
Seeking Alpha · 03/18 17:25
BUZZ-U.S. STOCKS ON THE MOVE-Nvidia, Tesla, Xpeng
Wall Street on track to open higher ahead of the U.S. Federal Reserve's meeting this week. Dow e-minis were up 0.19% in premarket trading. Top three NYSE percentage gainers premarket were Emerald Holding, Solidion Technology. Nasdaq up on recovery in tech-laden Nasdaq. Nvidia, Tesla, Xpeng are among the stocks on the move.
Reuters · 03/18 13:24
12 Health Care Stocks Moving In Monday's Pre-Market Session
Applied DNA Sciences (APDN) stock moved upwards by 33.1% to $0.49 during Monday's pre-market session. XTL Biopharmaceuticals (XTLB) shares increased by 19.31%. 2seventy bio (TSVT) shares rose 17.7%. Titan Pharma (TTNP) shares declined by 18.2% during the session.
Benzinga · 03/18 13:05
Weekly Report: what happened at TTNP last week (0311-0315)?
Weekly Report · 03/18 10:53
Weekly Report: what happened at TTNP last week (0304-0308)?
Weekly Report · 03/11 10:50
Weekly Report: what happened at TTNP last week (0226-0301)?
Weekly Report · 03/04 10:53
Weekly Report: what happened at TTNP last week (0219-0223)?
Weekly Report · 02/26 11:03
Weekly Report: what happened at TTNP last week (0212-0216)?
Weekly Report · 02/19 11:05
Weekly Report: what happened at TTNP last week (0205-0209)?
Weekly Report · 02/12 10:56
12 Health Care Stocks Moving In Thursday's Pre-Market Session
China SXT Pharmaceuticals (NASDAQ:SXTC) stock rose 122.5% to $4.05 during Thursday's pre-market session. The company's market cap rose to $2.2 million. Titan Pharma, Mineralys Therapeutics and Nutex Health were among the gainers. Jin Medical International shares decreased by 93.9% during the session.
Benzinga · 02/08 13:05
Weekly Report: what happened at TTNP last week (0129-0202)?
Weekly Report · 02/05 11:03
Weekly Report: what happened at TTNP last week (0122-0126)?
Weekly Report · 01/29 10:54
Titan Pharmaceuticals Regains Compliance with Nasdaq Listing
Titan Pharmaceuticals (TTNP) has released an update. The company now complies with the Nasdaq’s minimum bid price requirement and meets all other criteria for continued listing on The Nasdaq Capital Market. TTNP stock is down 2.7% in the last week.
TipRanks · 01/26 09:39
Titan Pharmaceut: Current report
Press release · 01/25 23:36
Titan pharmaceuticals notified of full compliance by NASDAQ
Healthcare Titan pharmaceuticals notified of full compliance by NASDAQ Jan. 25, 2024 4:34 PM ETTitan Pharmaceuticals, Inc. (TTNP) Stock. The company was notified by Nasdaq that it has regained compliance with the minimum $1.00 bid price requirement.
Seeking Alpha · 01/25 21:34
Weekly Report: what happened at TTNP last week (0115-0119)?
Weekly Report · 01/22 10:57
More
Webull provides a variety of real-time TTNP stock news. You can receive the latest news about Titan Pharmaceut through multiple platforms. This information may help you make smarter investment decisions.
About TTNP
Titan Pharmaceuticals, Inc. is a pharmaceutical company. The Company is engaged in developing therapeutics utilizing its long-term drug delivery platform, ProNeura, for the treatment of select chronic diseases. Its ProNeura continuous drug delivery system consists of a small, solid rod-shaped implant made from a mixture of ethylene-vinyl acetate (EVA), and a drug substance. Its first product, Probuphine (buprenorphine implant), is based on ProNeura technology, which is used for the maintenance treatment of opioid use disorder in clinically stable patients taking 8 milligrams (mg) or less a day of oral buprenorphine. Its product pipeline includes the Kappa Opioid Receptor Agonist (TP-2021) Implant and Nalmefene Implant. Its TP-2021 is used for the treatment of moderate-to-severe chronic pruritus. Its Nalmefene Implant is used for the prevention of relapse in opioid use disorder (OUD) patients following detoxification from opioids.